Tag: drug development

The Neuroscience Report—Vol. 24 (October 12, 2015): Treatment Paradigm Shifts in CNS

The Neuroscience Report—Vol. 24 (October 12, 2015): Treatment Paradigm Shifts in CNS

| October 12, 2015 | 0 Comments

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This Week’s Topic: Treatment […]

Continue Reading

The Neuroscience Report—Vol. 17 (August 24, 2015): Alzheimer’s Disease

The Neuroscience Report—Vol. 17 (August 24, 2015): Alzheimer’s Disease

| August 24, 2015 | 0 Comments

Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 17 (August 24, 2015): Alzheimer’s Disease Journal Articles Informed Consent, Participation […]

Continue Reading

The Neuroscience Report—Vol. 16 (August 17, 2015): Multiple Sclerosis

The Neuroscience Report—Vol. 16 (August 17, 2015): Multiple Sclerosis

| August 17, 2015 | 0 Comments

Welcome to the Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. Volume 16 (August 17, 2015): Multiple Sclerosis Journal Articles Electroconvulsive Therapy in […]

Continue Reading

Editor’s Message and Issue Highlights: May-June 2015

Editor’s Message and Issue Highlights: May-June 2015

| June 11, 2015 | 0 Comments

Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the journal, a compendium of abstracts from the 2014 CNS Summit poster presentations. Each year, the CNS Summit brings together drug development leaders from pharma, research sites, […]

Continue Reading

Editor’s Message and Issue Highlights—March–April 2015

Editor’s Message and Issue Highlights—March–April 2015

| April 23, 2015 | 0 Comments

Dear Colleagues: Welcome to the March–April 2015 issue of Innovations in Clinical Neuroscience (ICNS). First, I would like to call to your attention the supplement that accompanies this issue of ICNS, presented by the International Society for CNS Clinical Trials and Methodology (ISCTM), of which ICNS is the official publication.

Continue Reading

A message from the chair, ISCTM Scientific Publications

A message from the chair, ISCTM Scientific Publications

| April 20, 2015 | 0 Comments

Dear Colleagues: Twice a year, the International Society for CNS Clinical Trials and Methodology (ISCTM) brings together academic researchers, policy makers, and industry and government representatives to focus on promoting advances in the development and use of central nervous system (CNS) therapeutic agents. Over the past few years, this forum has specifically addressed the strategic […]

Continue Reading

Editor’s Message and January-February 2015 Issue Highlights

Editor’s Message and January-February 2015 Issue Highlights

| February 25, 2015 | 0 Comments

Dear Colleagues: Welcome to the January-February 2015 issue of Innovations in Clinical Neuroscience and to the beginning of our 12th year of publication. Over the years, we have sought to not only provide you with information on the latest, evidence-based treatment techniques for your patients, but also with information on how these new treatments are […]

Continue Reading

Editor’s Message and Issue Highlights: November-December 2014

Editor’s Message and Issue Highlights: November-December 2014

| December 7, 2014 | 0 Comments

Dear Colleagues: Welcome to the November–December 2014 issue of Innovations in Clinical Neuroscience. We start this issue with the first of what we hope to be a series of drug development guidance papers created by the collaborative efforts of the clinicians, investigators, industry scientists, and other entities involved in drug development who participate in the […]

Continue Reading